InsidersTradesSigma
Follow the Diamyd Medical AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Diamyd Medical AB has recorded 7 reports. Market capitalisation: €159.9m. The latest transaction was reported on 24 June 2026 (Purchase). Among the most active insiders: Anders Essen-Möller. The full history is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€596,975
7 ops.
Buy Volume
n/a
n/a
Sell Volume
47Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 June 2026
Declarations7 total
100,000 shares@ SEK 1.000.0059% mcap1.6% of flowAktieISIN SE0005162880FI:csv-c0583c028b9c2148656e
200,000 shares@ €0.09670.012% mcap100.0% of flowAktieISIN SE0020997468FI:A003X890-1
1,000 shares@ €0.90490.0005% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0024467914FI:A003N869-1
1,020 shares@ €0.72770.0004% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0024467914FI:A003N791-1
327,124 shares@ €0.73150.14% mcap42.9% of flowBTU (betald tecknad unit)ISIN SE0022760336FI:A003N796-1
435,630 shares@ €0.73150.19% mcap57.1% of flowBTU (betald tecknad unit)ISIN SE0005162880FI:A003N795-1
12,500 shares@ €0.72770.0055% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0024467914FI:A003N704-1
7 of 7 declarations
Acerca de Diamyd Medical AB
Diamyd Medical AB es una empresa biofarmacéutica sueca centrada en el desarrollo de tratamientos para la diabetes tipo 1. La empresa se especializa en terapias innovadoras basadas en proteínas recombinantes.